2012
DOI: 10.1017/s1041610211002754
|View full text |Cite
|
Sign up to set email alerts
|

Serotonin syndrome during treatment with low dose of escitalopram associated with miconazole mucoadhesive tablet: a suspected drug interaction

Abstract: Antidepressant treatments, including selective serotonin reuptake inhibitors, are associated in older adults with an increased risk of adverse effects compared to younger adults. This is partly explained by multiple drug use causing drug-drug interactions. In the present report, we describe a case of serotonin syndrome in an 88-year-old woman receiving a low dose of escitalopram. The onset of this episode could have been induced by a drug-drug interaction with an acute treatment by miconazole gingival adhesive… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…One such case involved an 88-year-old female who experienced an interaction between 5 mg of escitalopram and 50 mg of miconazole. 7 A second case involved a 27-year-old female who experienced an interaction between 10 mg of escitalopram and 50–60 mg of cyclobenzaprine. 8 Finally, a third case involved a 65-year-old female who experienced an interaction between 10 mg of escitalopram and 600 mg of the antibiotic linezolid.…”
Section: Discussionmentioning
confidence: 99%
“…One such case involved an 88-year-old female who experienced an interaction between 5 mg of escitalopram and 50 mg of miconazole. 7 A second case involved a 27-year-old female who experienced an interaction between 10 mg of escitalopram and 50–60 mg of cyclobenzaprine. 8 Finally, a third case involved a 65-year-old female who experienced an interaction between 10 mg of escitalopram and 600 mg of the antibiotic linezolid.…”
Section: Discussionmentioning
confidence: 99%
“…1 No single receptor appears to be responsible for the development of the Serotonin syndrome, although several studies suggest that agonism of serotonin-1A (5-HT1A) and serotonin-5A (5-HT2A) receptors contribute substantially to the condition. 2 Cocaine prevents serotonin uptake and its combination with esciolapram may lead to serotonin syndrome. 9 The diagnosis of Serotonin syndrome is made clinically.…”
Section: Clinical Medicine Insights: Case Reports 2012:5 Case Reportmentioning
confidence: 99%